Product overview
Type
Influenza, Pandemic (H1N1)
Commercial Name
Celtura
Manufacturer
Seqirus GmbH
URL
Responsible NRA
Paul-Ehrlich-Institut
Country
Germany
URL
Prequalification
Prequalification Status
Current: No Routine Production
Product description
Pharmaceutical Form
Liquid: ready to use
Presentation
Vial
Number of Doses
17
Diluent
Not Applicable
Route of Administration
Intramuscular
Shelf Life
6 months
Storage Temperature
2-8°C
Vaccine Vial Monitor
none
Secondary Packaging
10
Tertiary Packaging
Inner carton of 800 vials (13600 doses) [Dimensions: 38.9 x 24.4 x 24.7 cm]. Export box of 12 inner cartons (9600 vials/163,200 doses) [Dimensions: 120 x 100 x 125 cm]
Multidose Vial Policy
WHO recommends that opened vials of this vaccine may be kept for use in subsequent immunization sessions (up to a maximum of 28 days) provided the conditions outlined in the WHO Policy Statement: The use of opened multi-dose vials of vaccine in subsequent immunization sessions are met.
Vaccine Preservative
thiomersal
Vaccine Preservative Concentration
0.1mg/mL
Cold Chain Volume
1.34 cm3/dose (in secondary packaging)